Novavax given limited approval as booster New ATAGI advice permits Novavax for third dose and encourages those who had AstraZeneca as primary course to take mRNA booster.
How many people were ‘waiting for Novavax’? The approval of Novavax was long-awaited. Now its rollout is under way, newsGP assesses what response GPs are seeing on the ground.
ATAGI releases Moderna guidance for children aged 6–11 The RACGP has welcomed the announcement, but says more funding and support is needed for general practice.
Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
Australia the first to approve Moderna vaccine in young children Kids aged 6–11 will soon be able to receive the Moderna Spikevax COVID vaccine, after it received provisional approval for use in this cohort.
RACGP urges action on NT COVID-19 spread Hospitalisations are rising in the territory, with doctors concerned about complacency and the knock-on effects for primary care.
Novavax rollout fast-tracked After months of delays, the rollout of Australia’s fourth COVID vaccine began over the weekend.
More than 40 children given incorrect dose of COVID-19 vaccine No serious adverse effects were reported among the tiny proportion of children aged 5–11 who received an adult dose.
TGA approval clarifies AstraZeneca booster use While vaccinators could already use AstraZeneca as a booster in certain circumstances, the TGA decision may make the option clearer to the public.
Fourth dose now recommended for cancer patients over 16 The change in ATAGI advice will affect the COVID vaccine recommendations for cancer patients aged 16 and 17 with immediate effect.